Arjo AB (publ) (STO:ARJO.B)
Sweden · Delayed Price · Currency is SEK 27.60
0.00 (0.00%)
Aug 12, 2026, 10:12 AM CET
Arjo AB Market Cap
Arjo AB has a market cap or net worth of 7.52 billion as of August 11, 2026. Its market cap has decreased by -15.02% in one year.
Market Cap
7.52B
Enterprise Value
12.31B
Revenue
10.92B
Ranking
n/a
PE Ratio
19.58
Stock Price
27.60
ChartMarket Cap Chart
Since December 12, 2017, Arjo AB's market cap has increased from 6.71B to 7.52B, an increase of 12.06%. That is a compound annual growth rate of 1.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 7.52B | -13.80% |
| Dec 30, 2025 | 8.72B | -11.69% |
| Dec 30, 2024 | 9.88B | -7.97% |
| Dec 29, 2023 | 10.73B | 1.18% |
| Dec 30, 2022 | 10.61B | -64.86% |
| Dec 30, 2021 | 30.18B | 76.29% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 157.39B |
| Getinge AB | 65.15B |
| Sectra AB | 51.52B |
| Medicover AB | 36.17B |
| BioGaia AB | 11.28B |
| Xvivo Perfusion AB | 8.78B |
| MedCap AB | 7.95B |
| Synsam AB | 7.89B |